Medical Progress Report 2 | Appendix Table 1

Medical Progress Report No. 2 October 2005

Older Drugs, Shorter Lives? An Examination of the Health Effects of the Veterans Health Administration Formulary

Appendix Table 1: Priority Review Drugs Approved After 1997 Not Listed on 2005 National Formulary
ABARELIX	MIFEPRISTONE
ACAMPROSATE	NATALIZUMAB
ADEFOVIR	NITAZOXANIDE
ALITRETINOIN	NITISINONE
ALOSETRON	NITRIC OXIDE
ANAGRELIDE	ORLISTAT
APREPITANT	OSELTAMIVIR
ARSENIC	PEGVISOMANT
AZACITIDINE	PEMETREXED
BEVACIZUMAB	PEMIROLAST
BEXAROTENE	PIOGLITAZONE
BIMATOPROST	RALOXIFENE
BORTEZOMIB	REPAGLINIDE
CAPECITABINE	RIFAPENTINE
CASPOFUNGIN	ROFECOXIB
CELECOXIB	SACROSIDASE
CETUXIMAB	SIROLIMUS
CINACALCET	SODIUM OXYBATE
DALFOPRISTIN/QUINUPRISTIN	TEGASEROD
DAPTOMYCIN	TEMOZOLOMIDE
EPIRUBICIN	THALIDOMIDE
EPTIFIBATIDE	THYROTROPIN ALFA
ERLOTINIB	TIROFIBAN
FOMIVIRSEN	TREPROSTINIL
FONDAPARINUX	TROGLITAZONE
GANIRELIX	UNOPROSTONE
GEFITINIB	VALRUBICIN
KETOTIFEN	VERTEPORFIN
LEFLUNOMIDE	ZANAMIVIR
LEPIRUDIN	ZOLEDRONIC